Mitomicina-C para el tratamiento de los tumores superficiales de vejiga (Tis-Ta-Tl) con uno o más factores de riesgo

Archivos Espanoles de Urologia

Volumn 49, Issue 2, 1996, Pages 133-138

  Villaronga, Alberto ^a,b   Bellver, Enrique ^a   Perli, Gustavo ^a   Pautaso, Oscar ^a   Bengochea, Daniel ^a   Roldan, Raul Alfredo ^a   Podskubska, Oscar ^a   Belen, Raul ^a   Delgado, Gustavo ^a   Laberti, Oscar ^a   Lando, Rodolfo ^a   Rey, Horacio ^a   Bengio, Ruben ^a   Minuzzi, Luis ^a   Goldman, Enrique ^a   Milman, Angel ^a   Sanguinetti, Oscar ^a   Wernert, Oscar ^a  

^a Grupo Cooperativo Argentino O   (Argentina)

^b NONE   (Argentina)

Author keywords

Intravesical instillation; Mytomycin C; Superficial bladder carcinoma

Indexed keywords

MITOMYCIN C;

ADULT; AGED; ARTICLE; BLADDER TUMOR; CYSTITIS; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; HUMAN; INTRATUMORAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; RISK FACTOR;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, TRANSITIONAL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM STAGING; RISK FACTORS; URINARY BLADDER NEOPLASMS;

EID: 5344236053     PISSN: 00040614     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. HENEY, N.M.; NOCKS, B.N.; DALY, J.J.; y cols.: "TA and TI bladder cancer: occasion, recurrence and progression". Br. J. Urol., 54: 152, 1982
2. RIDDLE, T.R.; CHISHOLM, G.D.; TROFF, P.A.: "Flat carcinoma in situ of the bladder". Br. J. Urol., 47: 829, 1975
3. DEVITA, JR. V.; HELLMAN, S.; and ROSENBERG, SA (Eds).: "Cancer Principles & Practice of Oncology". 4th edition, pag 1057. JB Lippincott Company. 1993
4. SKINNER, D.G.: "Current perspectives in the management of high grade invasive bladder cancer". Cancer, 45: 1866, 1980
5. PROUT, GR JR.; GRIFFIN, P.P.; SHIPLEY, W.U.: "Bladder carcinoma as a systemic disease". Cancer, 43: 2532, 1979
6. JAKSE, G.; LOIDL, W.; SEEBER, G.; y cols.: "Stage Tl grade 3 transitional cell carcinoma of the bladder: An unfavorable tumor?". J. Urol., 137: 39, 1987
7. HERR, HW.; LIDONE, V.P.: "Intravesical therapy for superficial bladder cancer". AUA Update Series. Vol 8, lesson 12. Bellaire. Texas. American Urological Associates Office of Education. 1989
8. RAWLS, W.H.; LAMM. D.L.; LOWE, B.A.; y cols.: "Fatal sepsis following intravesical bacillus Calmette-Guerin administration for bladder cancer". J. Urol., 144: 1328, 1990
9. RICOSTORRENT, J.V.; MONROS LLISO, J.L. IBORRA, J.S.; y cols.: "Mitoxantrone (Mtx) versus mitomycin-C (MMC) in the ablative treatment of Ta, Tl superficial bladder tumors. Phase III, randomized prospective study". Archives Españoles de Urología. 45: 647, 1992
10. DE BRUIJIN, E.A.; SLEEBOOM, H.P.; VAN HELSDINGEN, P.J.; y cols.: "Pharmacodynamics and pharmacokinetics of intravesical mitomycin C upon different dwelling times". International Journal of Cancer, 51: 359, 1992
11. MILANI, C.; BASSI, P.; MENEGHINI, A.; y cols.: "Mitomycin-C in multiple superficial bladder tumors: short-term therapy, long-term results. Urologia Internationalis". 48: 154, 1992
12. Hollester, D.; Coleman, M.: "Hematological effects of intravesical thiotepa therapy for bladder cancer". JAMA, 224: 2065, 1980
13. WU, J.J.; YIN, Z.L.; ZHU, J.N.: "Endovesical instillation of mitomycin-C in preventing recurrence of superficial bladder carcinoma". Gan Tokagaku Ryoho, 19 (Suppl. 8): 1160, 1992
14. HORBARTH, K.; MAIER, U.; SUSANI, M.: "Value of bladder wash cytology in the followup of patients with bladder carcinoma receiving intravesical chemoprophylaxis with mitomycin-C". European Urology, 20: 93, 1991
15. HELLOTEN, S.; MANSSON, W..; HENRIKSON H.; y cols.: "Intravesical mitomycin C for carcinoma in situ of the urinary bladder". Scand. J. Urol. Nephrol., 24: 35, 1990
16. BADALAMENT, R.A.; HERR, H.W.; WONG, G.Y.: "A prospective randomized trial of maintenance vs non maintenance intravesical BCG therapy of superficial bladder cancer". J. Clin. Oncol., 5: 441, 1987.